On the public citation graph

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review

https://doi.org/10.3390/jcm10020193

0 signed · 162 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/pd.1700openalex-snapshot

Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast

inferredcites →https://doi.org/10.1007/s11892-018-1059-4openalex-snapshot

Biomarkers in Islet Cell Transplantation for Type 1 Diabetes

inferredcites →https://doi.org/10.1016/j.ajpath.2018.03.020openalex-snapshot

Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma

inferredcites →https://doi.org/10.1016/j.bdq.2019.100087openalex-snapshot

The emerging role of cell-free DNA as a molecular marker for cancer management

inferredcites →https://doi.org/10.1016/j.cancergen.2013.01.005openalex-snapshot

Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer

inferredcites →https://doi.org/10.1016/j.cca.2011.07.011openalex-snapshot

Methods for isolation of cell-free plasma DNA strongly affect DNA yield

inferredcites →https://doi.org/10.1016/j.cca.2015.11.009openalex-snapshot

Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients

inferredcites →https://doi.org/10.1016/j.clgc.2019.12.018openalex-snapshot

Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma

inferredcites →https://doi.org/10.1016/j.critrevonc.2019.06.005openalex-snapshot

Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology

inferredcites →https://doi.org/10.1016/j.eururo.2016.01.007openalex-snapshot

Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer

inferredcites →https://doi.org/10.1016/j.healun.2019.11.015openalex-snapshot

Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation

inferredcites →https://doi.org/10.1016/j.humimm.2014.06.010openalex-snapshot

Humoral immunity in hand transplantation: Anti-HLA and non-HLA response

inferredcites →https://doi.org/10.1016/j.humimm.2017.03.002openalex-snapshot

Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch

inferredcites →https://doi.org/10.1016/j.jmoldx.2016.07.003openalex-snapshot

Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients

inferredcites →https://doi.org/10.1016/j.jmoldx.2020.04.208openalex-snapshot

Sputum Cell-Free DNA

inferredcites →https://doi.org/10.1016/j.jtho.2016.05.035openalex-snapshot

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

inferredcites →https://doi.org/10.1016/j.mito.2018.07.008openalex-snapshot

Cell-free mitochondrial DNA in progressive multiple sclerosis

inferredcites →https://doi.org/10.1016/j.molmed.2020.01.012openalex-snapshot

Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living

inferredcites →https://doi.org/10.1016/j.semnephrol.2018.05.013openalex-snapshot

Epidemiology of IgA Nephropathy: A Global Perspective

inferredcites →https://doi.org/10.1016/j.transproceed.2015.08.035openalex-snapshot

Donor-Derived Cell-Free DNA Is a Novel Universal Biomarker for Allograft Rejection in Solid Organ Transplantation

inferredcites →https://doi.org/10.1016/j.transproceed.2019.04.051openalex-snapshot

A Noninvasive and Donor-independent Method Simultaneously Monitors Rejection and Infection in Patients With Organ Transplant

inferredcites →https://doi.org/10.1016/j.trre.2015.07.002openalex-snapshot

Immunological characteristics of the elderly allograft recipient

inferredcites →https://doi.org/10.1016/j.trre.2020.100542openalex-snapshot

Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation

inferredcites →https://doi.org/10.1016/s0140-6736(05)79055-3openalex-snapshot

Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients

inferredcites →https://doi.org/10.1016/s0959-437x(03)00026-1openalex-snapshot

Structure and dynamic behavior of nucleosomes

inferredcites →https://doi.org/10.1038/nbt.3520openalex-snapshot

Integrated digital error suppression for improved detection of circulating tumor DNA

inferredcites →https://doi.org/10.1038/nm.1789openalex-snapshot

Circulating mutant DNA to assess tumor dynamics

inferredcites →https://doi.org/10.1038/nm.3511openalex-snapshot

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA

inferredcites →https://doi.org/10.1038/nrc3066openalex-snapshot

Cell-free nucleic acids as biomarkers in cancer patients

inferredcites →https://doi.org/10.1038/s41416-020-01047-5openalex-snapshot

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond

inferredcites →https://doi.org/10.1038/s41436-020-0801-xopenalex-snapshot

Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma

inferredcites →https://doi.org/10.1038/s41467-018-04745-0openalex-snapshot

Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract

inferredcites →https://doi.org/10.1038/s41598-017-02905-8openalex-snapshot

Cell-free DNA from human plasma and serum differs in content of telomeric sequences and its ability to promote immune response

inferredcites →https://doi.org/10.1038/s41598-018-25810-0openalex-snapshot

Evaluation of pre-analytical factors affecting plasma DNA analysis

inferredcites →https://doi.org/10.1038/s41598-020-74245-zopenalex-snapshot

Serum metabolomics approach to monitor the changes in metabolite profiles following renal transplantation

inferredcites →https://doi.org/10.1053/j.ajkd.2004.04.040openalex-snapshot

Late urinary tract infection after renal transplantation in the United States

inferredcites →https://doi.org/10.1073/pnas.0507904102openalex-snapshot

Detection and quantification of mutations in the plasma of patients with colorectal tumors

inferredcites →https://doi.org/10.1073/pnas.1013924108openalex-snapshot

Universal noninvasive detection of solid organ transplant rejection

inferredcites →https://doi.org/10.1073/pnas.1105422108openalex-snapshot

Detection and quantification of rare mutations with massively parallel sequencing

inferredcites →https://doi.org/10.1073/pnas.1517494112openalex-snapshot

Noninvasive monitoring of infection and rejection after lung transplantation

inferredcites →https://doi.org/10.1080/15257771003708298openalex-snapshot

Assessment of Cell-Free DNA with Microvascular Complication of Type II Diabetes Mellitus, Using PCR and Elisa

inferredcites →https://doi.org/10.1080/15384047.2019.1598759openalex-snapshot

Life and death of circulating cell-free DNA

inferredcites →https://doi.org/10.1086/301800openalex-snapshot

Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis

inferredcites →https://doi.org/10.1093/ndt/gfz091openalex-snapshot

The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation

inferredcites →https://doi.org/10.1097/ftd.0000000000000239openalex-snapshot

Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury

inferredcites →https://doi.org/10.1097/ftd.0000000000000549openalex-snapshot

Liquid Biopsies to Monitor Solid Organ Transplant Function: A Review of New Biomarkers

inferredcites →https://doi.org/10.1097/ftd.0000000000000640openalex-snapshot

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

inferredcites →https://doi.org/10.1097/mot.0000000000000722openalex-snapshot

Future developments in kidney transplantation

inferredcites →https://doi.org/10.1097/tp.0000000000002083openalex-snapshot

Beta Cell Death by Cell-free DNA and Outcome After Clinical Islet Transplantation

inferredcites →https://doi.org/10.1097/tp.0000000000003393openalex-snapshot

The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation

inferredcites →https://doi.org/10.1097/tp.0b013e31827a19ccopenalex-snapshot

Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation

inferredcites →https://doi.org/10.1097/tp.0b013e318295ee5aopenalex-snapshot

A Rapid Noninvasive Assay for the Detection of Renal Transplant Injury

inferredcites →https://doi.org/10.1097/txd.0000000000001063openalex-snapshot

Plasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data

inferredcites →https://doi.org/10.1111/1759-7714.13178openalex-snapshot

Saliva‐derived cfDNA is applicable for EGFR mutation detection but not for quantitation analysis in non‐small cell lung cancer

inferredcites →https://doi.org/10.1111/ajt.14625openalex-snapshot

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

inferredcites →https://doi.org/10.1111/ajt.15142openalex-snapshot

Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction

inferredcites →https://doi.org/10.1111/ajt.15289openalex-snapshot

Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients

inferredcites →https://doi.org/10.1111/ajt.15339openalex-snapshot

Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study

inferredcites →https://doi.org/10.1111/ajt.15416openalex-snapshot

Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study

inferredcites →https://doi.org/10.1111/ajt.15822openalex-snapshot

High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury

inferredcites →https://doi.org/10.1111/ctr.14053openalex-snapshot

Prognostic value of the donor‐derived cell‐free DNA assay in acute renal rejection therapy: A prospective cohort study

inferredcites →https://doi.org/10.1111/j.1600-6143.2008.02159.xopenalex-snapshot

Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions

inferredcites →https://doi.org/10.1111/tri.12371openalex-snapshot

The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes

inferredcites →https://doi.org/10.1111/tri.13554openalex-snapshot

Quantitative PCR of INDEL s to measure donor‐derived cell‐free DNA —a potential method to detect acute rejection in kidney transplantation: a pilot study

inferredcites →https://doi.org/10.1126/scitranslmed.3007803openalex-snapshot

Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection

inferredcites →https://doi.org/10.1126/scitranslmed.aat4921openalex-snapshot

Enhanced detection of circulating tumor DNA by fragment size analysis

inferredcites →https://doi.org/10.1126/scitranslmed.aba2501openalex-snapshot

A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection

inferredcites →https://doi.org/10.1134/s0006297906060010openalex-snapshot

Proteins involved in binding and cellular uptake of nucleic acids

inferredcites →https://doi.org/10.1136/bmjdrc-2019-001078openalex-snapshot

Serum cell-free DNA and progression of diabetic kidney disease: a prospective study

inferredcites →https://doi.org/10.1155/2016/3693096openalex-snapshot

Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer

inferredcites →https://doi.org/10.1158/0008-5472.can-18-0074openalex-snapshot

Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models

inferredcites →https://doi.org/10.1159/000479523openalex-snapshot

Circulating Cell-Free DNA Levels in Patients with Metastatic Renal Cell Carcinoma

inferredcites →https://doi.org/10.1172/jci105479openalex-snapshot

Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

inferredcites →https://doi.org/10.1172/jci107165openalex-snapshot

The Occurrence of Single-Stranded DNA in the Serum of Patients with Systemic Lupus Erythematosus and Other Diseases

inferredcites →https://doi.org/10.1177/1756284819841896openalex-snapshot

Cell-free DNA testing: future applications in gastroenterology and hepatology

inferredcites →https://doi.org/10.1186/gm434openalex-snapshot

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing

inferredcites →https://doi.org/10.1186/s12882-019-1549-xopenalex-snapshot

Urinary cell-free mitochondrial and nuclear deoxyribonucleic acid correlates with the prognosis of chronic kidney diseases

inferredcites →https://doi.org/10.1186/s12885-018-4433-3openalex-snapshot

Update on the types and usage of liquid biopsies in the clinical setting: a systematic review

inferredcites →https://doi.org/10.1186/s40169-020-0257-2openalex-snapshot

Detection of bladder cancer using urinary cell‐free DNA and cellular DNA

inferredcites →https://doi.org/10.1186/s40425-019-0653-6openalex-snapshot

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment

inferredcites →https://doi.org/10.1371/journal.pcbi.1005629openalex-snapshot

Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype

inferredcites →https://doi.org/10.1371/journal.pmed.1002286openalex-snapshot

Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study

inferredcites →https://doi.org/10.1371/journal.pone.0023418openalex-snapshot

High Fragmentation Characterizes Tumour-Derived Circulating DNA

inferredcites →https://doi.org/10.1371/journal.pone.0041162openalex-snapshot

FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing

inferredcites →https://doi.org/10.1371/journal.pone.0171988openalex-snapshot

Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment

inferredcites →https://doi.org/10.1371/journal.pone.0194630openalex-snapshot

Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA

inferredcites →https://doi.org/10.1371/journal.pone.0208207openalex-snapshot

Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay

inferredcites →https://doi.org/10.1373/clinchem.2003.024893openalex-snapshot

Size Distributions of Maternal and Fetal DNA in Maternal Plasma

inferredcites →https://doi.org/10.1373/clinchem.2005.058974openalex-snapshot

Soluble Donor DNA Concentrations in Recipient Serum Correlate with Pancreas-Kidney Rejection

inferredcites →https://doi.org/10.1373/clinchem.2013.210328openalex-snapshot

Digital Droplet PCR for Rapid Quantification of Donor DNA in the Circulation of Transplant Recipients as a Potential Universal Biomarker of Graft Injury

inferredcites →https://doi.org/10.1373/clinchem.2018.298323openalex-snapshot

Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA

inferredcites →https://doi.org/10.1681/asn.2016091034openalex-snapshot

Cell-Free DNA and Active Rejection in Kidney Allografts

inferredcites →https://doi.org/10.18632/oncotarget.3041openalex-snapshot

Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform

inferredcites →https://doi.org/10.23876/j.krcp.20.003openalex-snapshot

Diagnosis of renal transplant rejection: Banff classification and beyond

inferredcites →https://doi.org/10.3109/19401736.2012.696625openalex-snapshot

Circulating cell-free mitochondrial DNA as a novel cancer biomarker: opportunities and challenges

inferredcites →https://doi.org/10.3389/fcvm.2016.00033openalex-snapshot

An Algorithm Measuring Donor Cell-Free DNA in Plasma of Cellular and Solid Organ Transplant Recipients That Does Not Require Donor or Recipient Genotyping

inferredcites →https://doi.org/10.3389/fimmu.2019.01064openalex-snapshot

ccf-mtDNA as a Potential Link Between the Brain and Immune System in Neuro-Immunological Disorders

inferredcites →https://doi.org/10.3389/fimmu.2020.00342openalex-snapshot

Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study

inferredcites →https://doi.org/10.3390/cancers11040458openalex-snapshot

Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol

inferredcites →https://doi.org/10.3390/diagnostics10030152openalex-snapshot

Plasma Concentrations of Extracellular DNA in Acute Kidney Injury

inferredcites →https://doi.org/10.3390/ijms20184463openalex-snapshot

Noninvasive Urinary Monitoring of Progression in IgA Nephropathy

inferredcites →https://doi.org/10.3390/jcm8010019openalex-snapshot

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR

inferredcites →https://doi.org/10.3390/jcm8040499openalex-snapshot

A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury

inferredcites →https://doi.org/10.3390/jcm8101622openalex-snapshot

Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

inferredcites →https://doi.org/10.3390/jcm9051480openalex-snapshot

The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status

inferredcites →https://doi.org/10.3390/jcm9051543openalex-snapshot

Increased Cell-Free DNA Plasma Concentration Following Liver Transplantation Is Linked to Portal Hepatitis and Inferior Survival

inferredcites →https://doi.org/10.3390/jcm9072118openalex-snapshot

Living Donor Kidney Transplantation Improves Graft and Recipient Survival in Patients with Multiple Kidney Transplants

inferredcites →https://doi.org/10.3390/jcm9082325openalex-snapshot

Clinical and Analytical Validation of a Novel Urine-Based Test for the Detection of Allograft Rejection in Renal Transplant Patients

inferredcites →https://doi.org/10.3399/bjgp09x420572openalex-snapshot

Cell-free fetal DNA and non-invasive prenatal diagnosis

inferredcites →https://doi.org/10.3748/wjg.v20.i4.957openalex-snapshot

Circulating and stool nucleic acid analysis for colorectal cancer diagnosis

inferredcites →https://doi.org/10.3978/j.issn.2305-5839.2013.06.06openalex-snapshot

Circulating free DNA in the management of breast cancer.

inferredcites →https://doi.org/10.4172/2329-9495.1000161openalex-snapshot

Circulating Cell-Free Mitochondrial DNA as Biomarker of Cardiovascular risk: New Challenges of Old Findings

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4665933openalex-extracted

inferred← citeshttps://doi.org/10.1007/978-3-032-07686-1_7openalex-snapshot

Donor-Derived Cell-Free DNA in Acute and Chronic Rejection of Solid Allograft Transplantation

inferred← citeshttps://doi.org/10.1007/978-981-97-7292-6_7openalex-snapshot

Ultrasound Nanoimaging II

inferred← citeshttps://doi.org/10.1007/s10157-026-02889-8openalex-snapshot

Applications of donor-derived cell-free DNA in kidney transplantation healthcare: view from a prospective single-center study

inferred← citeshttps://doi.org/10.1007/s40472-021-00349-8openalex-snapshot

Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation

inferred← citeshttps://doi.org/10.1016/j.bja.2023.03.006openalex-snapshot

Multi-omic molecular profiling and network biology for precision anaesthesiology: a narrative review

inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2024.116367openalex-snapshot

Cell free DNA as a new prognostic biomarker for COVID-19, A prospective cohort study

inferred← citeshttps://doi.org/10.1016/j.humimm.2021.07.006openalex-snapshot

Cell-free DNA diagnostics in transplantation utilizing next generation sequencing

inferred← citeshttps://doi.org/10.1016/j.kint.2021.11.034openalex-snapshot

Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study

inferred← citeshttps://doi.org/10.1016/j.kint.2022.06.033openalex-snapshot

Histology versus molecular surveillance: claims and evidence

inferred← citeshttps://doi.org/10.1016/j.semnephrol.2022.01.007openalex-snapshot

Novel Biomarkers in Kidney Transplantation

inferred← citeshttps://doi.org/10.1016/j.trim.2025.102307openalex-snapshot

Diagnostic value of dd-cfDNA and CXCL-10 in kidney allograft recipients for identifying acute rejection

inferred← citeshttps://doi.org/10.1016/j.trim.2026.102407openalex-snapshot

Advances in biosensors for monitoring immune responses and allograft rejection in organ transplantation

inferred← citeshttps://doi.org/10.1016/j.trre.2021.100649openalex-snapshot

The clinical value of donor-derived cell-free DNA measurements in kidney transplantation

inferred← citeshttps://doi.org/10.1080/14789450.2024.2389829openalex-snapshot

Advancing kidney transplant outcomes: the role of urinary proteomics in graft function monitoring and rejection detection

inferred← citeshttps://doi.org/10.1093/clinchem/hvac053openalex-snapshot

Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries

inferred← citeshttps://doi.org/10.1093/ndt/gfad120openalex-snapshot

Early kinetics of donor-derived cell-free DNA after transplantation predicts renal graft recovery and long-term function

inferred← citeshttps://doi.org/10.1097/mot.0000000000000979openalex-snapshot

Cell-free DNA in lung transplantation: research tool or clinical workhorse?

inferred← citeshttps://doi.org/10.1097/tp.0000000000004482openalex-snapshot

Understanding Donor-derived Cell-free DNA in Kidney Transplantation: An Overview and Case-based Guide for Clinicians

inferred← citeshttps://doi.org/10.1097/tp.0000000000005007openalex-snapshot

Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant

inferred← citeshttps://doi.org/10.1097/txd.0000000000001610openalex-snapshot

Use of Donor-derived Cell-free DNA to Inform Tapering of Immunosuppression Therapy in Kidney Transplant Recipients: An Observational Study

inferred← citeshttps://doi.org/10.1111/ctr.70019openalex-snapshot

Changes in Donor‐Derived Cell‐Free DNA Before and After Rejection and De Novo DSA Detection in Primary and Repeat Kidney Transplant Recipients

inferred← citeshttps://doi.org/10.1111/iji.12654openalex-snapshot

Non‐invasive molecular biomarkers for monitoring solid organ transplantation: A comprehensive overview

inferred← citeshttps://doi.org/10.12659/aot.939750openalex-snapshot

Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ Transplantation

inferred← citeshttps://doi.org/10.1371/journal.pone.0282332openalex-snapshot

Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects

inferred← citeshttps://doi.org/10.20944/preprints202407.0492.v1openalex-snapshot

Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients during Two Years: Experience of One Center

inferred← citeshttps://doi.org/10.21203/rs.3.rs-1536352/v1openalex-snapshot

Comparison of Methods for Donor-Derived Cell-Free DNA Quantification in Plasma and Urine from Solid Organ Transplant Recipients

inferred← citeshttps://doi.org/10.21203/rs.3.rs-1536352/v2openalex-snapshot

Comparison of Methods for Donor-Derived Cell-Free DNA Quantification in Plasma and Urine from Solid Organ Transplant Recipients

inferred← citeshttps://doi.org/10.2174/0118715273366438250408120558openalex-snapshot

Cell-Free DNA, a Noninvasive Biomarker for Prediction and Detection of Neurodegenerative Diseases, New Insights, and Perspectives

inferred← citeshttps://doi.org/10.21926/obm.transplant.2302190openalex-snapshot

Biomarkers in the Management of the Lung Transplant Allograft: A Focus on Donor-derived Cell-free DNA

inferred← citeshttps://doi.org/10.2215/cjn.03840322openalex-snapshot

Longitudinal Evaluation of Donor-Derived Cellfree DNA in Pediatric Kidney Transplantation

inferred← citeshttps://doi.org/10.2217/bmm-2021-0968openalex-snapshot

Cell-Free Dna As A Solid-Organ Transplant Biomarker: Technologies and Approaches

inferred← citeshttps://doi.org/10.2217/pgs-2023-0138openalex-snapshot

Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation

inferred← citeshttps://doi.org/10.23876/j.krcp.23.286openalex-snapshot

Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejection

inferred← citeshttps://doi.org/10.3389/fgene.2023.1089830openalex-snapshot

Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients

inferred← citeshttps://doi.org/10.3389/fimmu.2023.1240347openalex-snapshot

Cell-free DNA measurement of three genomes after allogeneic MSC therapy in kidney transplant recipients indicates early cell death of infused MSC

inferred← citeshttps://doi.org/10.3389/fimmu.2024.1461480openalex-snapshot

Application of graft-derived cell-free DNA for solid organ transplantation

inferred← citeshttps://doi.org/10.3389/ti.2024.13919openalex-snapshot

Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection Monitoring

inferred← citeshttps://doi.org/10.3390/biology10090906openalex-snapshot

Current Trends in Cell-Free DNA Applications. Scoping Review of Clinical Trials

inferred← citeshttps://doi.org/10.3390/biomedicines13102325openalex-snapshot

Donor-Derived Cell-Free DNA in Allograft Transplantation: Exaggerated Hope or Cautious Reality?

inferred← citeshttps://doi.org/10.3390/ijms23010131openalex-snapshot

The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases

inferred← citeshttps://doi.org/10.3390/ijms24033051openalex-snapshot

Circulating Microbial Cell-Free DNA in Health and Disease

inferred← citeshttps://doi.org/10.3390/jcm13133778openalex-snapshot

Recent Insights in Noninvasive Diagnostic for the Assessment of Kidney and Cardiovascular Outcome in Kidney Transplant Recipients

inferred← citeshttps://doi.org/10.3390/life14111491openalex-snapshot

Early Monitoring of Donor-Derived Cell-Free DNA in Kidney Allograft Recipients Followed-Up for Two Years: Experience of One Center

inferred← citeshttps://doi.org/10.4103/ijn.ijn_152_22openalex-snapshot

Donor-derived cell-free DNA and active rejection in renal allografts

inferred← citeshttps://doi.org/10.4103/ijot.ijot_127_23openalex-snapshot

Donor-derived Cell-free DNA: Advanced Biomarkers for Enhanced Kidney Recipient Surveillance

inferred← citeshttps://doi.org/10.5500/wjt.v15.i4.104349openalex-snapshot

Utility and limitations of the use of donor-derived cell-free DNA in kidney transplantation

inferred← citeshttps://doi.org/10.56766/ntms.1852728openalex-snapshot

Donor-Derived Cell-Free DNA in Solid Organ Transplantation: An Evidence-Based Review

inferred← citeshttps://doi.org/10.5958/2322-0996.2022.00011.4openalex-snapshot

Cell-free DNA: An opportunity to revolutionize advance disease detection

inferred← citeshttps://doi.org/10.6002/ect.2024.0300openalex-snapshot

Tracking Acute Rejection in Heart Transplant Recipients by Using Donor-Derived Cell-Free DNA: A Promising Approach.

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.